Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
T.ATE
Alternate Symbol(s):
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ATE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 16, 2024 9:36am
RE:RE: Upcoming Discussion
Dan must have an ace up his sleeve for thursday to get the stock price comfortably above the $1 mark. the usual blah blah blah combined with the dillution of shares will move the stock back under $1
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 16, 2024 9:11am
RE:RE:Upcoming Discussion ...
Regardless of easier or harder - both acute and chronic are huge markets on their own. Also, acute is a short window for painkiller usage which makes OTENA a perfect candidate. Chronic is
...more
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(385)
•••
Benedictus
X
View Profile
View Bullboard History
Comment by
Benedictus
on Jan 15, 2024 11:48pm
RE:Upcoming Discussion ...
I recall Dan saying a long while back that partnering opportunities for acute would be easier than chronic. Do you agree with that or is that just Dan speak in the same vein as his AME debacle "
...more
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 15, 2024 10:59am
Insider Buying
no one selling their vested rsu's but instead trading for common shares. although not a huge amount Filing Date Transaction Date Insider Name
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 14, 2024 12:27pm
Upcoming Discussion ...
January 18th ... Learn about the benefits of otenaproxesul’s new formulation, dive into Antibe’s recently released data and Phase II planning, and explore the future of pain management. ----------
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 14, 2024 10:34am
RE:RE:RE:RE:After today🤞
It is not in the right time for Institutional investors - but - that could change quickly as risk is reduced and success is had. Also, it isn't the institutional investors who would
...more
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Jan 13, 2024 5:55pm
RE:RE:RE:After today🤞
This company is too small for any institution to have any interest unless they decide to buy the whole thing
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 12, 2024 8:34pm
RE:After today🤞
If anything - January 18th is about the power of OTENA. Some may be obvious - the rest will require some "reading between the lines." As always.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 12, 2024 8:31pm
RE:RE:After today🤞
True - agreed !!! These are retail investors ... and I'd bet many are just coming back now (past owners of ATE). Important institutional buying will be closely related to a US market move.
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Jan 12, 2024 12:56pm
RE:After today🤞
IMO we are a ways off from any Ititutional buying...
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 12, 2024 11:22am
After today🤞
only 3 more full trading days before the 18th. pretty sure the stock will be moving higher before the start of the conversation. maybe we get some big players, institunial buying during and after the
...more
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 10, 2024 10:07am
Back down close to $1
dan is going to have to serve up some red meat next week if he wants to get that 6.5M maybe some insider buying would help keep the price up. i do not think p2 will start untill march, that is
...more
(805)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 06, 2024 2:41am
Series of virtual events?
Antibe Therapeutics (@AntibeThera) · X X (Twitter) https://twitter.com/AntibeThera
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 04, 2024 5:37pm
RE:RE:RE:RE:RE:RE:RE:RE:Any predictions
The significance is this ... The warrants are priced at $1.00 from Jan 16th to Feb 15th (or similar) while the presentation by Dan/Joe falls within that window. (on Jan 18th). Not only is that
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company